All over the world, legal cannabis is big business - and Britain is no exception. Investors, patients and politicians are all caught up in the so called 'green rush' - but what is the truth behind the hype? Join The Spectator to find out.

‍

Programme and Timings

14:00 – 14:30 Registration and refreshments

14:30 – 14:35 Welcome from chair Alastair Stewart

‍

14:35 – 15:20 Cannabis and Healthcare

Tonia Antoniazzi MP, All-Party Parliamentary Group on Medical Cannabis under Prescription

Professor Mike Barnes, neurologist and chief medical officer, European Cannabis Holdings

Crispin Blunt, co-chair, All Party Parliamentary Group on Drug Policy Reform

Hannah Deacon, campaigner, End Our Pain & Alfie Dingley’s mother

‍

15:20 – 16:05 Cannabis and Capital

Gregg Batterby, managing director, Europe for Althea Group Holding

Jonathan Deverill, partner, Corporate, DAC Beachcroft

Melissa Sturgess, CEO, Ananda Developments

Marcus Stuttard, head of UK Primary Markets, London Stock Exchange

‍

16:05 – 17:00 Drinks and networking

‍

In association with DAC Beachcroft and supported by Prohibition Partners 

‍